| Date Filed | Type | Description |
| 06/12/2023 |
3
| Forbes William P (EVP, Chief Development Officer) has filed a Form 3 on HERON THERAPEUTICS, INC. /DE/ |
| 04/03/2023 |
4
| Forbes William P (Director) has filed a Form 4 on Beyond Air, Inc.|
Txns:
| Bought 5,000 shares
@ $6.67, valued at
$33.4k
|
|
| 03/31/2023 |
4
| Forbes William P (Director) has filed a Form 4 on Beyond Air, Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.28, valued at
$251.2k
|
|
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/07/2022 |
4
| Forbes William P (Director) has filed a Form 4 on Beyond Air, Inc.|
Txns:
| Granted 30,000 options to buy
@ $6.87, valued at
$206.1k
|
|
| 02/15/2022 |
4
| Forbes William P (Chief Development Officer) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 137,500 options to buy
@ $0.511, valued at
$70.3k
|
|
| 03/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/03/2015 |
4
| Forbes William P (President, Medical, R&D & CDO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD|
Txns:
| Disposed/sold 51,714 shares
@ $173, valued at
$8.9M
|
|
| 03/11/2015 |
4
| Forbes William P (President, Medical R&D and CDO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD|
Txns:
| Sold 42,880 shares
@ $157.84, valued at
$6.8M
|
|
| 03/09/2015 |
4
| Forbes William P (EVP Research&Devel & CDO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD|
Txns:
| Sold 20,000 shares
@ $157.96, valued at
$3.2M
|
|
| 01/08/2015 |
4
| Forbes William P (EVP Research&Devel & CDO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD|
Txns:
| Paid exercise price by delivering 10,997 shares
@ $114.94, valued at
$1.3M
|
|
| 11/14/2014 |
4
| Forbes William P (EVP Research&Devel & CDO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD|
Txns:
| Sold 11,079 shares
@ $95.05, valued at
$1.1M
Exercised 11,200 options to buy
@ $17.53, valued at
$196.3k
Exercised 6,250 options to buy
@ $17.63, valued at
$110.2k
|
|
| 08/26/2014 |
4
| Forbes William P (EVP Research&Devel & CDO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD|
Txns:
| Granted 19,809 shares
@ $158.3, valued at
$3.1M
|
|
| 07/03/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/21/2014 |
4
| Forbes William P (EVP Research&Devel & CDO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD|
Txns:
| Granted 19,809 shares
@ $100.66, valued at
$2M
|
|
| 01/10/2014 |
4
| Forbes William P (EVP Research&Devel & CDO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD|
Txns:
| Sold 8,000 shares
@ $90.06, valued at
$720.5k
Exercised 8,000 options to buy
@ $17.53, valued at
$140.2k
|
|
| 01/06/2014 |
4
| Forbes William P (EVP Research&Devel & CDO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD|
Txns:
| Paid exercise price by delivering 8,851 shares
@ $89.94, valued at
$796.1k
|
|
| 07/26/2013 |
4
| Forbes William P (EVP Research&Devel & CDO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD|
Txns:
| Sold 3,000 shares
@ $69.91, valued at
$209.7k
Sold 6,000 shares
@ $70.96, valued at
$425.8k
Sold 3,000 shares
@ $71.88, valued at
$215.6k
Exercised 12,000 options to buy
@ $17.53, valued at
$210.4k
|
|
| 07/03/2013 |
4
| Forbes William P (EVP Research&Devel & CDO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD|
Txns:
| Paid exercise price by delivering 4,835 shares
@ $66.15, valued at
$319.8k
|
|
| 04/22/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/12/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/04/2013 |
4
| Forbes William P (EVP Research&Devel & CDO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD|
Txns:
| Paid exercise price by delivering 5,052 shares
@ $40.47, valued at
$204.5k
|
|
| 07/05/2012 |
4
| Forbes William P (EVP Research&Devel & CDO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD|
Txns:
| Paid exercise price by delivering 4,107 shares
@ $54.44, valued at
$223.6k
|
|
| 05/21/2012 |
4
| Forbes William P (EVP Research&Devel & CDO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD|
Txns:
| Sold 7,100 shares
@ $51.35, valued at
$364.6k
Sold 2,900 shares
@ $52.26, valued at
$151.6k
Exercised 10,000 options to buy
@ $17.53, valued at
$175.3k
|
|
| 04/27/2012 |
4
| Forbes William P (EVP Research&Devel & CDO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD|
Txns:
| Granted 20,713 shares
@ $0 |
|
| 02/15/2012 |
4
| Forbes William P (EVP Research&Devel & CDO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD|
Txns:
| Sold 4,297 shares
@ $50, valued at
$214.9k
Exercised 4,297 options to buy
@ $17.53, valued at
$75.3k
|
|
| 01/19/2012 |
4
| Forbes William P (EVP Research&Devel & CDO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD|
Txns:
| Sold 1,119 shares
@ $50.059, valued at
$56k
Sold 125 shares
@ $50, valued at
$6.3k
Exercised 1,119 options to buy
@ $17.53, valued at
$19.6k
Exercised 125 options to buy
@ $17.53, valued at
$2.2k
|
|
| 01/05/2012 |
4
| Forbes William P (EVP Research&Devel & CDO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD|
Txns:
| Paid exercise price by delivering 2,506 shares
@ $47.85, valued at
$119.9k
|
|
|